Targeting the human MUC1 oncoprotein: a tale of two proteins.
Kufe
Donald W
DW
Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. Donald_Kufe@dfci.harvard.edu
D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001729:Bismuth / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D051379:Mice; D008969:Molecular Sequence Data; D018396:Mucin-1 / Q000737:chemistry / Q000187:drug effects / Q000502:physiology*; D015513:Oncogene Proteins / Q000502:physiology*; D010051:Ovarian Neoplasms / Q000532:radiotherapy*; D021122:Protein Subunits; D016499:Radioimmunotherapy
D000911:Antibodies, Monoclonal; C060192:MUC1 protein, human; D018396:Mucin-1; D015513:Oncogene Proteins; D021122:Protein Subunits; D001729:Bismuth